Evaluation in vitro de l'activité des écorces de tige de Anogeissus leiocarpus (DC) Guill. et Perr. (Combretaceae) sur des bactéries responsables de maladies courantes en Afrique et criblage phytochimique ; Tel : (225) 08687153 RESUME Les bactéries sont à l'origine de réel problème de santé publique à cause de leur implication dans de nombreuses maladies. Leur résistance aux antibiotiques est devenue l'un des problèmes les plus importants dans la lutte contre les maladies infectieuses dans le monde. L'objectif de ce travail est d'évaluer l'activité antibactérienne des extraits hexanique, méthanolique 70% (v/v) et aqueux des écorces de tige de Anogeissus leiocarpus (DC) Guill. et Perr. (Combretaceae), une plante médicinale de la flore ivoirienne, contre les bactéries des genres Staphylococcus, Pseudomonas et les entérobactéries (Shigella sp., Salmonella Typhimurium, Escherichia coli et Proteus mirabilis) par la méthode de diffusion en milieu gélosé dans des cupules et la méthode de macro-dilution en milieu liquide . Les extraits aqueux et méthanolique 70% (v/v) ont été retenus pour la détermination des paramètres antibactériens (CMI et CMB), en raison de leurs activités sur l'ensemble des bactéries sélectionnées. Par ailleurs, une analyse qualitative par chromatographie sur couche mince (CCM), effectuée sur les différents extraits, a permis de détecter plusieurs groupes de composés chimiques parmi lesquels les saponosides, les tanins, les flavonoïdes, les polyphénols, les alcaloïdes et les sesquiterpènes dont des effets antibactériens sont connus. Les CMI obtenues, sont comprises entre 0,7 ± 0,0 et 12,5 ± 0,0 mg/ml. Quant aux CMB, elles varient de 3,1 ± 0,0 à 25,0 ± 0,0 mg/ml. Ce travail justifie l'utilisation traditionnelle de Anogeissus leiocarpus dans le traitement de diverses pathologies et plus particulièrement celles d'origine bactérienne. ABSTRACTThe bacteria are causing real public health problem because of their involvement in many diseases. Antibiotic resistance has become one of the most important issues in the fight against infectious diseases worldwide. The objective of this study was to evaluate the antibacterial activity of extracts hexane, methanol 70% (v / v) aqueous Anogeissus leiocarpus (DC) Guill. and Perr. (Combretaceae) stem bark, a medicinal plant from the Ivorian flora against bacteria of the genus Staphylococcus, Pseudomonas and Enterobacteriaceae (Shigella spp., Salmonella Typhimurium, Escherichia coli and Proteus mirabilis) by the middle diffusion method agar in the wells and method in liquid medium macro-dilution. The aqueous extracts methanol and 70% (v / v) were used to determine antibacterial settings (MIC and MBC), because of their activities on all of the selected bacteria. Moreover, a qualitative analysis by thin layer chromatography (TLC) carried out on the different extracts was detected more chemical compounds of groups including saponins, tannins, flavonoids, polyphenols, alkaloids and sesquiterpenes including antibacterial effects are known. The MICs obtained are between 0.7...
The SARS-CoV-2 outbreak has highlighted the need for broad-spectrum antivirals against coronaviruses (CoVs). Here, pheophorbide a (Pba) was identified as a highly active antiviral molecule against HCoV-229E after bioguided fractionation of plant extracts. The antiviral activity of Pba was subsequently shown for SARS-CoV-2 and MERS-CoV, and its mechanism of action was further assessed, showing that Pba is an inhibitor of coronavirus entry by directly targeting the viral particle. Interestingly, the antiviral activity of Pba depends on light exposure, and Pba was shown to inhibit virus-cell fusion by stiffening the viral membrane as demonstrated by cryo-electron microscopy. Moreover, Pba was shown to be broadly active against several other enveloped viruses, and reduced SARS-CoV-2 and MERS-CoV replication in primary human bronchial epithelial cells. Pba is the first described natural antiviral against SARS-CoV-2 with direct photosensitive virucidal activity that holds potential for COVID-19 therapy or disinfection of SARS-CoV-2 contaminated surfaces.
The SARS-CoV-2 outbreak has highlighted the need for broad-spectrum antivirals against coronaviruses (CoVs). Here, pheophorbide a (Pba) was identified as a highly active antiviral molecule against HCoV-229E after bioguided fractionation of plant extracts. The antiviral activity of Pba was subsequently shown for SARS-CoV-2 and MERS-CoV, and its mechanism of action was further assessed, showing that Pba is an inhibitor of coronavirus entry by directly targeting the viral particle. Interestingly, the antiviral activity of Pba depends on light exposure, and Pba was shown to inhibit virus-cell fusion by stiffening the viral membrane as demonstrated by cryo-electron microscopy. Moreover, Pba was shown to be broadly active against several other enveloped viruses, and reduced SARS-CoV-2 and MERS-CoV replication in primary human bronchial epithelial cells. Pba is the first described natural antiviral against SARS-CoV-2 with direct photosensitive virucidal activity that holds potential for COVID-19 therapy or disinfection of SARS-CoV-2 contaminated surfaces.
Millions of people are still infected with hepatitis C virus (HCV) nowadays. Although recent antivirals targeting HCV proteins are very efficient, they are not affordable for many people infected with this virus. Therefore, new and more accessible treatments are needed. Several Ivorian medicinal plants are traditionally used to treat “yellow malaria”, a nosological category including illness characterized by symptomatic jaundice such as hepatitis. Therefore, some of these plants might be active against HCV. An ethnobotanical survey in Côte d’Ivoire allowed us to select such medicinal plants. Those were first extracted with methanol and tested for their anti-HCV activity. The most active ones were further studied to specify their IC50 and to evaluate their toxicity in vitro. Greener solvents were tested to obtain extracts with similar activities. Following a phytochemical screening, tannins of the most active plants were removed before re-testing on HCV. Some of these tannins were identified by UPLC-MS and pure molecules were tested against HCV. Out of the fifteen Ivorian medicinal plants selected for their putative antiviral activities, Carapa procera DC. and Pericopsis laxiflora (Benth. ex Baker) Meeuwen were the most active against HCV (IC50: 0.71 and 0.23 μg/ml respectively) and not toxic for hepatic cells. Their crude extracts were rich in polyphenols, including tannins such as procyanidins A2 which is active against HCV. The same extracts without tannin lost their anti-HCV activity. Replacing methanol by hydro-ethanolic solvent led to tannins-rich extracts with similar antiviral activities, and higher than that of aqueous extracts.
Anogeissus leiocarpus (DC.) Guill. & Perr. (Combretaceae) et Combretum collinum Fresen. (Combretaceae) sont deux plantes de la flore ivoirienne couramment utilisées pour traiter plusieurs pathologies telles que les affections cutanées, le paludisme et la fatigue générale. Ce travail s’inscrit dans le cadre de la valorisation de cette flore. Il vise donc à évaluer l’activité antibactérienne des extraits méthanoliques bruts des feuilles de Combretum collinum et des écorces de racines de Anogeissus leiocarpus sur la croissance "in vitro" des souches de Staphylococcus aureus résistantes à la méticilline. La méthode de diffusion en milieu gélosé (solide) a été utilisée pour évaluer la sensibilité des souches bactériennes aux extraits et à déterminer les concentrations minimales inhibitrices (CMI), Quant au screening phytochimique, il a été réalisé par une chromatographie sur couche mince (CCM). La concentration minimale inhibitrice est comprise entre 0,62 mg/ml et 1,25 mg/ml pour Anogeissus leiocarpus et est de 0,325 mg/ml pour Combretum collinum. Le screening phytochimique a révélé la présence de flavonoïdes et de tanins dans l’extrait méthanolique de Anogeissus leiocarpus alors que dans l’extrait méthanolique de Combretum collinum, ce sont des acides phénoliques qui ont été mis en évidence. Il ressort donc que ces deux plantes sont dotées d’un important pouvoir antibactérien et contiennent plusieurs composés chimiques. Elles pourraient donc constituer des voies de prospection pour la recherche de nouvelles molécules antibactériennes en réalisant une étude bio-guidée des extraits bruts et en évaluant leur cytotoxicité sur des cellules hépatiques saines.Mots clés: Antibactérienne, plantes médicinales, flore ivoirienne, extraits methanoliques English Title: Phytochemical screening of methanolic extracts from leaves of Combretum collinum and roots of Anogeisus leiocarpus and in vitro antibacterial effect on multiresistant strains of Staphylococcus aureus Both Anogeissus leiocarpus (DC.) Guill. & Perr. (Combretaceae) and Combretum collinum Fresen. (Combretaceae) are Ivorian national flora plants commonly used in treating skin disorders, malaria, and general fatigue. The current study consists of the valorization of this flora, and aims therefore at revealing antibacterial activity of the methanol crude extracts obtained from stem bark and leaves of the respective plants, against Methicillin-resistant Staphylococcus aureus strains. Agar gel diffusion method was used to assess bacteria susceptibility, and broth dilution method allowed determination of minimum inhibition concentrations (MICs). These parameters varied from 0.62 mg/ml to 1.25 mg/ml for Anogeissus leiocarpus, while they reached 0.325 mg/ml for Combretum collinum. In addition, phytochemical screening brought about flavonoids and tanins for the plant, and phenolic acids for the other one. In conclusion, these named plants contain several chemical compounds with antibacterial properties, and could be of great interest in the search of new molecular compounds provided with antibacterial activity through bio-guided experiments. Furthermore, they could best hold value by testing those methanol extracts over hepatic sane cells for cytotoxicity assessment. Keywords: antibacterial, medicinal plants, Ivorian national flora, methanolic extracts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.